FRAZIER LIFESCIENCES ACQUISITION CORPORATION

(FLAC)
SummaryQuotesChartsNewsCompanyFinancials 
Business Summary
Frazier Lifesciences Acquisition Corporation is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. It intends to identify opportunities in the biotechnology sector. It has conducted no operations and has generated no revenues.

Number of employees : 4 people.
Managers
Name Title Age Since
James N. Topper, Dr. Chairman & Chief Executive Officer 59 2003
David J. Topper Chief Financial Officer & Director 53 2020
Max M. Nowicki, Dr. Vice President-Acquisitions 33 -
Gordon Empey Vice President & General Counsel 52 2017
Members of the board
Name Title Age Since
James N. Topper, Dr. Chairman & Chief Executive Officer 59 2003
Robert F. Baltera Independent Director 55 -
Michael Bigham Independent Director 63 -
Carol Giltner Gallagher, Dr. Independent Director 56 2020
Krishna R. Polu, Dr. Independent Director 47 2020
David J. Topper Chief Financial Officer & Director 53 2020
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 14,301,000 14,301,000 100.0% 0 0.0% 80.6%
Stock B 1 3,450,000 0 0.0% 0 0.0%
Shareholders
NameEquities%
Frazier Management LLC 1,000,000 6.99%
Alyeska Investment Group LP 753,492 5.27%
Ecor1 Capital LLC 587,615 4.11%
Citadel Advisors LLC 553,272 3.87%
D. E. Shaw & Co. LP 508,840 3.56%
Millennium Management LLC 450,462 3.15%
Ensign Peak Advisors, Inc. 450,000 3.15%
DG Capital Management LLC 440,000 3.08%
Myda Advisors LLC 410,000 2.87%
Governors Lane LP 350,000 2.45%
Brand Portfolio
In partnership withAllbrands.markets
More brands of Frazier Lifesciences Acquisition Corporation